Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia.
Saved in:
| Title: | Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. |
|---|---|
| Authors: | Gregorova M; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Morse D; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Brignoli T; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Steventon J; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Hamilton F; North Bristol NHS Trust, Bristol, United Kingdom., Albur M; North Bristol NHS Trust, Bristol, United Kingdom., Arnold D; North Bristol NHS Trust, Bristol, United Kingdom., Thomas M; North Bristol NHS Trust, Bristol, United Kingdom., Halliday A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Baum H; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Rice C; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Avison MB; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Davidson AD; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Santopaolo M; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Oliver E; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Goenka A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Finn A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Wooldridge L; Bristol Veterinary School in the Faculty of Health Sciences, Bristol, United Kingdom., Amulic B; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Boyton RJ; Department of Infectious Disease, Imperial College London, London, United Kingdom.; Lung Division, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom., Altmann DM; Department of Infectious Disease, Imperial College London, London, United Kingdom., Butler DK; Department of Infectious Disease, Imperial College London, London, United Kingdom., McMurray C; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom., Stockton J; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom., Nicholls S; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom., Cooper C; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom., Loman N; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom., Cox MJ; Lung Division, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom., Rivino L; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Massey RC; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom. |
| Source: | ELife [Elife] 2020 Dec 17; Vol. 9. Date of Electronic Publication: 2020 Dec 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
